United States · FDA National Drug Code directory
Buspirone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82804-963_1521109d-8386-472f-9483-f1fe9f7ed152
- Product NDC
- 82804-963
- Form
- TABLET
- Composition / generic term
- buspirone hydrochloride
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200727
- Source listing expiry
- 20271231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (82804-963-00) · 82804-963-00
- 1000 TABLET in 1 BOTTLE (82804-963-11) · 82804-963-11
- 30 TABLET in 1 BOTTLE (82804-963-30) · 82804-963-30
- 500 TABLET in 1 BOTTLE (82804-963-55) · 82804-963-55
- 60 TABLET in 1 BOTTLE (82804-963-60) · 82804-963-60
- 120 TABLET in 1 BOTTLE (82804-963-72) · 82804-963-72
- 90 TABLET in 1 BOTTLE (82804-963-90) · 82804-963-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →